MedPath

comparsion between two drugs for the treatment of facial pigmentatio

Phase 1
Conditions
Health Condition 1: L811- Chloasma
Registration Number
CTRI/2021/08/035625
Lead Sponsor
ROHAILKHAND MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Those who are willing for study

2. Moderate to severe melasma

3. Age (18-60) years.

4. Mentally stable, oriented and coherent patients.

Exclusion Criteria

1. Pregnancy and Lactation

2. Melasma inducing drugs.

3. Patients on photosensitizing drugs or thyroid hormones.

4. Patients on Hormone replacement therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath